Unknown

Dataset Information

0

Bornyl cis-4-Hydroxycinnamate Suppresses Cell Metastasis of Melanoma through FAK/PI3K/Akt/mTOR and MAPK Signaling Pathways and Inhibition of the Epithelial-to-Mesenchymal Transition.


ABSTRACT: Bornyl cis-4-hydroxycinnamate, a bioactive compound isolated from Piper betle stems, has the potential for use as an anti-cancer agent. This study investigated the effects of bornyl cis-4-hydroxycinnamate on cell migration and invasion in melanoma cells. Cell migration and invasion were compared in A2058 and A375 melanoma cell lines treated with/without bornyl cis-4-hydroxycinnamate (1?6 µM). To examine whether bornyl cis-4-hydroxycinnamate has a potential anti-metastatic effect on melanoma cells, cell migration and invasion assays were performed using a Boyden chamber assay and a transwell chamber in A2058 and A375 cells. Gelatin zymography was employed to determine the enzyme activities of MMP-2 and MMP-9. Cell lysates were collected for Western blotting analysis of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors of metalloproteinase-1/2 (TIMP-1/2), as well as key molecules in the mitogen-activated protein kinase (MAPK), focal adhesion kinase (FAK)/ phosphatidylinositide-3 kinases (PI3K)/Akt/ mammalian target of rapamycin (mTOR), growth factor receptor-bound protein 2 (GRB2) signaling pathways. Our results demonstrated that bornyl cis-4-hydroxycinnamate is a potentially useful agent that inhibits melanoma cell migration and invasion, and altered melanoma cell metastasis by reducing MMP-2 and MMP-9 expression through inhibition of the FAK/PI3K/Akt/mTOR, MAPK, and GRB2 signaling pathways. Moreover, bornyl cis-4-hydroxycinnamate inhibited the process of the epithelial-to-mesenchymal transition in A2058 and A375 melanoma cells. These findings suggested that bornyl cis-4-hydroxycinnamate has potential as a chemotherapeutic agent, and warrants further investigation for its use in the management of human melanoma.

SUBMITTER: Yang TY 

PROVIDER: S-EPMC6121392 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bornyl <i>cis</i>-4-Hydroxycinnamate Suppresses Cell Metastasis of Melanoma through FAK/PI3K/Akt/mTOR and MAPK Signaling Pathways and Inhibition of the Epithelial-to-Mesenchymal Transition.

Yang Tzu-Yen TY   Wu Mei-Li ML   Chang Chi-I CI   Liu Chih-I CI   Cheng Te-Chih TC   Wu Yu-Jen YJ  

International journal of molecular sciences 20180724 8


Bornyl <i>cis</i>-4-hydroxycinnamate, a bioactive compound isolated from <i>Piper betle</i> stems, has the potential for use as an anti-cancer agent. This study investigated the effects of bornyl <i>cis</i>-4-hydroxycinnamate on cell migration and invasion in melanoma cells. Cell migration and invasion were compared in A2058 and A375 melanoma cell lines treated with/without bornyl <i>cis</i>-4-hydroxycinnamate (1⁻6 µM). To examine whether bornyl <i>cis</i>-4-hydroxycinnamate has a potential anti  ...[more]

Similar Datasets

| S-EPMC10128503 | biostudies-literature
| S-EPMC5983650 | biostudies-literature
| S-EPMC5752536 | biostudies-literature
| S-EPMC4807832 | biostudies-literature
| S-EPMC9377914 | biostudies-literature
| S-EPMC10417648 | biostudies-literature
2016-12-31 | GSE59882 | GEO
| S-EPMC6725910 | biostudies-literature
| S-EPMC7487371 | biostudies-literature
| S-EPMC7733797 | biostudies-literature